跳至主要内容
临床试验/CTRI/2023/05/053279
CTRI/2023/05/053279招募中Unknown

A prospective, post-market clinical data analysis in patients undergoing cardioversion ordefibrillation using Skanrays Defibrillators

Skanray Technologies Limited1 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2023年8月6日最近更新:

试验速览

阶段
Unknown
状态
招募中
入组人数
65
试验地点
1
主要终点
To collect clinical data of patients undergoing defibrillation, cardioversion or pacing using

研究概览

简要总结

Skanray’s Defibrillators are portable external defibrillator with manual or semi automatic control along with pacing and monitoring of ECG, SpO2 (optional) and NiBP (optional). It employs bi-phasic current or duration controlled shock waveform. The Skanray’s Defibrillators defibrillator / monitor is used for the treatment of life threatening cardiac dysrhythmias by qualified medical personnel familiarised in the operation of the device and qualified by training in basic life support, advanced cardiac life support, or defibrillation, in a professional healthcare facility under controlled environment. Indicated for manual defibrillation therapy, semi-AED therapy and pacing therapy. This device is approved by European CE and CDSCO (DCGI).

研究设计

研究类型
Observational

入排标准

年龄范围
1.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Data from the subject that meets the below-mentioned criteria shall be collected.
  • â— Patients with indications for defibrillation/cardioversion/pacing.
  • â— Male and female subjects who weigh above 10 kg.

排除标准

  • â— Unsafe conditions or surroundings for the use of Direct Current â— Contraindications for defibrillation A A responsive patient with spontaneous breathing and a palpable pulse. B Asystole or pulseless electrical activity PEA â— Contraindications for cardioversion.
  • arrhythmias due to enhanced automaticity, such as digitalis toxicity of digitalis-associated tachycardia, sinus tachycardia, multifocal atrial tachycardia and junctional tachycardia. Catecholamine-induced arrhythmia having a homogeneous depolarization state Eg CPVT, shall be excluded. â— Contraindications for pacing.
  • asymptomatic subjects with a reasonably stable rhythm.

结局指标

主要结局

To collect clinical data of patients undergoing defibrillation, cardioversion or pacing using

时间窗: Within 1 day.

Skanrays Defibrillators.

时间窗: Within 1 day.

次要结局

  • To collect the following data with the use of Skanray defibrillators(a. Clinical feedback from the investigator.)

研究者

申办方类型
Other [Medical Device Manufacturer]

研究点 (1)

Loading locations...

相似试验

Post-Market Clinical Data Analysis With Skanrays... | 临床试验